LabCompass

Alex Straiker

Medicine · Indiana University

OpenAlex ORCID
Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchSleep and Wakefulness ResearchForensic Toxicology and Drug AnalysisNeurotransmitter Receptor Influence on Behavior

Publications

99

Citations

4,705

Est. group size

—

Recurring co-author estimate

Active years

28

Publishing since 1999

Research summary
AI-generated

Alex Straiker studies cannabinoids and their receptors (the biological targets that compounds from cannabis, such as THC and CBD, act on). Much of the work explores how these receptors can be adjusted with new chemical compounds to treat conditions such as glaucoma and eye pressure, pain, and inflammation, often using mouse models and drug-design approaches. The research spans neuroscience, pharmacology, and medicinal chemistry.

Cannabinoid receptor pharmacologyDrug design and medicinal chemistryGlaucoma and intraocular pressureNeuropharmacology and sensory circuitsPain and inflammation

Publication activity has been fairly steady over the last decade, with a peak around 2021 and a recent average of about three to five papers per year.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 3.4/year recently
2017: 4 publications172018: 7 publications182019: 5 publications192020: 5 publications202021: 10 publications10212022: 3 publications222023: 3 publications232024: 5 publications242025: 5 publications252026: 1 publication26
Recent publications
Publishes in
  • Investigative Ophthalmology & Visual Science×7
  • Pharmacological Research×4
  • Molecules×4
  • Scientific Reports×4
  • The Cambridge Structural Database×4

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile